about
The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.Spotlight on opicapone as an adjunct to levodopa in Parkinson's disease: design, development and potential place in therapy.Rational drug discovery design approaches for treating Parkinson's disease.New treatments for levodopa-induced motor complications.Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.Promising therapeutic agents for the treatment of Parkinson's disease.Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspective.Safinamide: A Review in Parkinson's Disease.MAO inhibitors and their wider applications: a patent review.1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
P2860
Q34512544-547A1907-0759-485D-9FAE-50F59BEB8F76Q34550037-8627C786-A47A-40AE-B144-2245378EB4C4Q38520864-52DC5C20-5ED6-4FA4-AC90-E94639E43F3EQ38570434-892C17AC-4C2A-4351-8181-3F7D03DAA666Q38636630-15738C31-D149-488D-A517-C984BEB0C008Q38767711-2C55AE6F-99F3-4F5C-AA80-CEAE4F9EA72CQ38947507-7F213DB5-00CB-408F-B272-7802E4A6AEBAQ39097789-159C9439-D6A9-4A4F-8FA5-703FA77C6BFDQ47658356-6D1B5C2B-7CD4-44A1-BE19-A1446CD75EAFQ48108548-823929D9-5921-4E22-BA9F-70975084A09A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Safinamide for the treatment of Parkinson's disease.
@en
type
label
Safinamide for the treatment of Parkinson's disease.
@en
prefLabel
Safinamide for the treatment of Parkinson's disease.
@en
P2860
P1476
Safinamide for the treatment of Parkinson's disease
@en
P2093
Livia Dézsi
P2860
P304
P356
10.1517/13543784.2014.897694
P407
P577
2014-03-21T00:00:00Z